The Serendipitous Story of SGLT2 Inhibitors in Heart Failure

Circulation. 2019 May 28;139(22):2537-2541. doi: 10.1161/CIRCULATIONAHA.119.040514. Epub 2019 Mar 18.

Authors

Subodh Verma¹, John J V McMurray²

Affiliations

¹ Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Canada (S.V.).
² British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (J.J.V.M.).

PMID: 30882236
DOI: 10.1161/CIRCULATIONAHA.119.040514

No abstract available

Keywords: Editorials; SGLT2 inhibitors; diabetes mellitus; heart failure.

Publication types

Editorial
Comment

MeSH terms

Benzhydryl Compounds
Diabetes Mellitus, Type 2*
Glucosides
Heart Failure*
Humans
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Benzhydryl Compounds
Glucosides
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin